Paper of the Week 2013


PDF-Link for insitution's members only (password required, see infoboard of UVCM, Inselspital)


2013-25-10

  • Shin A et al: The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus. Clin Gastroenterol Hepatol. 2013 Nov;11(11):1453-1459.e4. Epub 2013 Apr 30. DOI-Link - PDF for institution members

2013-18-10

  • Duboc H et al: Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 2013;62:531–539. DOI-Link - PDF for institution members
  • Jones L: Letter to the editor regarding the report of Duboc et al: connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease. Gut April 2013 Vol 62 No 4. DOI-Link - PDF for institution members

2013-01-09

2013-15-08

2013-19-07


2013-07-12

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease


2013-07-05

Nurse observation during colonoscopy increases polyp detection


2013-06-25

Diagnostic of gastrointestinal CMV-infection


2013-06-17

The intermediate filament protein, vimentin, is a regulator of NOD2 activity


2013-05-30

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease


2013-05-16

A Controlled Trial of Gluten-Free Diet in Patients With Irritable Bowel Syndrome-Diarrhea: Effects on Bowel Frequency and Intestinal Function


2013-05-02

Surgical versus medical therapy for GERD


2013-04-30

Phosphatidylcholine for ulcerative colitis


2013-04-15

CO2 for gastrointestinal endoscopy


2013-04-03

CVI/GI risk calculation for Aspirin users


2013-03-27

PPI vs. Fluticason for treatment of eosinophilic esophagitis

  • Moawad FJ et al.: Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol. 2013 Mar;108(3):366-72. http://www.ncbi.nlm.nih.gov/pubmed/23399553 - PDF-Link for insitution's members
  • Editorial by Hirano: Should patients with suspected eosinophilic esophagitis undergo a therapeutic trial of proton pump inhibition? Am J Gastroenterol. 2013 Mar;108(3):373-5. http://www.ncbi.nlm.nih.gov/pubmed/23459046 -  PDF-Link for institution's members

Viscous versus nebulized steroid for treatment of eosinophilic esophagitis


2013-03-20

Pancreatic stents for prophylaxis of pancreatitis


2013-03-13

CO2 vs. air insufflation for GI endoscopy


2013-03-06

Esophageal sphincter device


2013-02-20

Outcome of MALT-lymphoma after H. pylor eradication

2013-02-13

H. pylori-positive chronic gastritis as risk factor for colonic neoplasm


2013-02-06

Carvedilol for primary prophylaxis of esophageal variceal bleeding


2013-01-30

Fecal duodenal infusion for recurrent C. difficile infection


2013-01-23

Bariatric surgery for prevention of DM type 2


2013-01-09

Screening of asymptomatic high risk individuals


  •  
  •  
  •  
  •  
© 2012-2015 Gastroenterology & Mucosal Immunology, Bern, Switzerland
Swiss Web Design